Synthetic biology company launches JV to commercialize gas-to-liquids bioconversion; isobutanol first target
Green Car Congress
MARCH 28, 2014
Although Intrexon’s engineered methanotroph produces isobutanol, commercial scale-up is a challenge; expression of a heterologous pathway for product generation places additional metabolic burdens on the cell, as carbon is diverted from primary to exogenous metabolic pathways for product production. Prior to Intrexon, Groban was at LS9.).
Let's personalize your content